[Cl-].[Br-].ClC1N=C2N=C(CCC)NC2=C(C)C=1.Br.[Br:18][C:19]1[N:24]=[C:23]2[N:25]=[C:26]([CH2:28][CH2:29][CH3:30])[NH:27][C:22]2=[C:21]([CH3:31])[CH:20]=1.[H-].[Na+].[CH2:34](Br)[C:35]1[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=1>C(O)(=O)C.CN(C=O)C>[CH2:34]([N:25]1[C:23]2=[N:24][C:19]([Br:18])=[CH:20][C:21]([CH3:31])=[C:22]2[N:27]=[C:26]1[CH2:28][CH2:29][CH3:30])[C:35]1[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=1
7-Methyl-2-propylimidazo[4,5-b]pyridine-5-carboxylic acid or the 2-ethyl analog is prepared from 7-methyl-2-propylimidazo[4,5b]pyridine or the 2-ethyl analog by treatment with m-chloroperoxybenzoic acid to obtain the N-oxide which is then treated with POCl3 to give 5-chloro-7-methyl-2-propylimidazo-[4,5-b]pyridine or 2-ethyl analog. The chloride is then exchanged for a bromide by reaction of 5-chloro-7-methyl-2-propylimidazo[4,5-b]pyridine or the 2-ethyl analog with HBr in acetic acid. The resulting 5-bromo-7-methyl-2-propylimidazo[4,5-b]- pyridine or 2-ethyl analog is treated with NaH in DMF followed by benzyl bromide to obtain 3-benzyl-5-bromo-7-methyl-2-propylimidazo[4,5-b]pyridine or its corresponding 2-ethyl analog which is in turn treated with CuCN in hot pyridine to obtain 3-benzyl-5-cyano-7-methyl-2-propylimidazo[4,5-b]pyridine or the corresponding 2-ethyl analog. The cyano compound is hydrolyzed to 3-benzyl-7-methyl-2-propylimidazo-[4,5-b]pyridine-5-carboxylic acid or the corresponding 2-ethyl analog by treatment with H2SO4 --H2O. This acid is esterified by reaction with MeOH--HCl. The benzyl group is removed by hydrogenation at 1 atm. in MeOH--HCl solution using Pd(OH)2 as catalyst. This compound can be alkylated as described earlier and the product methyl ester is converted to the carboxylic acid by treatment with hydroxide.
불러오는 중…
